The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmpyrean Regulatory News (EME)

Share Price Information for Empyrean (EME)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.475
Bid: 0.40
Ask: 0.55
Change: 0.00 (0.00%)
Spread: 0.15 (37.50%)
Open: 0.475
High: 0.00
Low: 0.00
Prev. Close: 0.475
EME Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction: Exercise of Options

2 Mar 2015 09:42

RNS Number : 2263G
Empyrean Energy PLC
02 March 2015
 

This announcement replaces the Exercise of Options announcement released today under RNS number 2184G at 09.15am.

 

The exercise price of the options exercised by John Laycock is £0.08 per share. All other details remain unchanged and the full amended announcement appears below.

 

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

2 March 2015

Empyrean Energy PLC ("Empyrean" or "the Company")

Exercise of Options & Extension of Expiry Date of Options

 

Empyrean announces that it has today issued 300,000 ordinary shares of 0.2 pence each ("Ordinary Shares") following the exercise of options at a price of £0.08 per share by John Laycock, a director of the Company. Application will be made for the new Ordinary Shares to be admitted to trading on AIM. Admission is expected to take place on 5 March 2015. These Ordinary Shares will rank pari passu with the existing Ordinary Shares.

 

Following this exercise, John Laycock has an interest in 1,200,000 Ordinary Shares, representing 0.54% per cent of the enlarged issued share capital of the Company.

 

Following the transaction, Empyrean's total issued share capital will comprise 221,833,853 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

Empyrean also notifies that the remuneration committee has recommended, and the board has resolved, to amend the remuneration and incentivisation arrangements of the board of directors (the "Board") in light of the recent pressure on the oil price and as part of a review being undertaken to reduce fixed costs and to ensure the close alignment of the interests of the Board with those of shareholders.

 

Firstly, Empyrean notifies that the remuneration committee has recommended, and the board has resolved, to reduce all Director's salary payments by 10%. The salary changes will come into effect beginning of April 2015.

 

Secondly, 14,400,000 existing options granted to Directors and the Company Secretary (the "Options"), which are currently scheduled to expire on 2 March 2015, have been amended to expire 19 July 2016. The Company confirms that all other terms of the Options remain unchanged.

 

A previous tranche of options over 11,100,000 Ordinary Shares, which were amended on 20 March 2014 to expire on 9 January 2015 (being the date falling four months following the publication of the Company's Annual Report & Accounts for the period to 31 March 2014) were not exercised by the option-holders owing to the ongoing strategic review and formal sale process at that time. The exercise price of the Options represents an approximate 25% premium to Empyrean's closing price of £0.06375 on 26 February 2015.

 

The Options represent approximately 6.5 per cent. of the current issued share capital of the Company, approximately 6.1 per cent. of total issued capital when diluted for the Options and approximately 5% of the total issued capital when diluted for all outstanding options and securities.

 

** ENDS **

For further information please visit www.empyreanenergy.com or contact the following:

 

Empyrean Energy plc

Tom Kelly

Tel: +61 8 9481 0389

Cenkos Securities plc

Neil McDonald

nmcdonald@cenkos.com

Tel: +44 (0) 131 220 9771

Nick Tulloch

ntulloch@cenkos.com

Tel: +44 (0) 131 220 9772

St Brides Partners Ltd

Hugo de Salis

hugo@stbridespartners.co.uk

Tel: +44 (0) 20 7236 1177

Elisabeth Cowell

elisabeth@stbridespartners.co.uk

Tel: +44 (0) 20 7236 1177

Lottie Brocklehurst

lottie@stbridespartners.co.uk

Tel: +44 (0) 20 7236 1177

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCJTMLTMBJMMRA
Date   Source Headline
5th Apr 20247:00 amRNSDirector/PDMR Shareholding
28th Mar 20247:57 amRNSMako Gas Sale Key Terms Signed with PGN
23rd Feb 20247:39 amRNSMinisterial Approval of Mako Gas Price
13th Feb 20247:00 amRNSEmpyrean completes £700,000 Placing
31st Jan 20247:00 amRNSDuyung PSC Update
18th Dec 202311:34 amRNSInterim Results
20th Nov 20232:40 pmRNSChange of Nominated Adviser
27th Sep 202312:58 pmRNSResult of AGM
15th Sep 20237:00 amRNSIssue of Salary Sacrifice Shares
12th Sep 20237:13 amRNSKey Terms Agreed for Long-Term Gas Sales Agreement
4th Sep 20237:00 amRNSPosting of Annual Report and Notice of AGM
1st Sep 202312:30 pmRNSFinal Results
30th May 20237:36 amRNSCapital raising, Debt Restructure & Company Update
2nd May 20237:00 amRNSMako gas field - Update
4th Jan 20234:40 pmRNSSecond Price Monitoring Extn
4th Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
20th Dec 20227:00 amRNSInterim Results
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSMako Gas - Approval of Updated Plan of Development
19th Oct 20221:19 pmRNSResults of General Meeting
27th Sep 202212:54 pmRNSResult of AGM
26th Sep 202212:01 pmRNSPosting of Annual Report and Notice of GM
16th Sep 20227:08 amRNSFinal Results
9th Sep 20227:00 amRNSMako Gas Project - Updated Plan of Development
2nd Sep 20229:04 amRNSPosting of Notice of Annual General Meeting
10th Jun 20227:00 amRNSSecond phase of exploration for Topaz Prospect
7th Jun 20227:00 amRNSChange of Registered Office Address
23rd May 20228:40 amRNSHolding(s) in Company
12th May 20224:41 pmRNSSecond Price Monitoring Extn
12th May 20224:36 pmRNSPrice Monitoring Extension
10th May 202211:45 amRNSCapital raising, drill analysis & debt restructure
4th May 20227:33 amRNSProposed drilling of Topaz Prospect
27th Apr 20227:00 amRNSJade well reached Total Depth
25th Apr 202211:59 amRNSHolding(s) in Company
21st Apr 20228:37 amRNSExercise of Warrants
19th Apr 20227:00 amRNSBlock 29/11, China - Jade drilling update
13th Apr 20227:43 amRNSDrilling update at Jade prospect
11th Apr 202212:32 pmRNSExercise of Warrants
11th Apr 20227:00 amRNSDrilling commences at Jade prospect
8th Apr 20229:55 amRNSExercise of Warrants
8th Apr 20227:00 amRNSBlock 29/11, China - NH9 rig on Jade location
4th Apr 20227:00 amRNSBlock 29/11, China – NH9 rig to mobilise
30th Mar 20228:16 amRNSBlock 29/11, China - Jade well update
28th Mar 20228:01 amRNSPartial Conversion of Convertible Note
25th Mar 20227:34 amRNSRig Mobilisation and Anticipated Spud Date
16th Mar 20229:52 amRNSPartial Conversion of Convertible Note
11th Mar 20227:42 amRNSBlock 29/11, China – Jade drilling update
10th Mar 20227:00 amRNSEmpyrean moves to SETS trading platform

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.